Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Assets (2016 - 2026)

Champions Oncology (CSBR) has 15 years of Assets data on record, last reported at $30.2 million in Q4 2025.

  • For Q4 2025, Assets rose 19.5% year-over-year to $30.2 million; the TTM value through Oct 2025 reached $30.2 million, up 19.5%, while the annual FY2025 figure was $32.3 million, 23.77% up from the prior year.
  • Assets reached $30.2 million in Q4 2025 per CSBR's latest filing, down from $30.5 million in the prior quarter.
  • Across five years, Assets topped out at $36.4 million in Q4 2022 and bottomed at $24.9 million in Q3 2024.
  • Average Assets over 5 years is $30.3 million, with a median of $30.0 million recorded in 2023.
  • Peak YoY movement for Assets: soared 67.56% in 2021, then fell 25.9% in 2024.
  • A 5-year view of Assets shows it stood at $29.3 million in 2021, then rose by 24.13% to $36.4 million in 2022, then dropped by 22.19% to $28.3 million in 2023, then decreased by 10.79% to $25.2 million in 2024, then increased by 19.5% to $30.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets were $30.2 million in Q4 2025, $30.5 million in Q3 2025, and $32.3 million in Q2 2025.